Physician profile
Robert E Luckey
NPI 1184744104
$5,504.77
in general payments reported to CMS, 2019-2025
18 companies · $661 in 2025
The $661 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,444 · 2020: $158 · 2021: $710 · 2022: $767 · 2023: $574 · 2024: $1,191 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,425.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,719.05 | 2019-2025 | Total30, Acrysof Iq Vivity, Precision7 |
| Bausch & Lomb Americas INC. | $1,210.97 | 2022-2025 | Infuse, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $565.64 | 2019-2021 | |
| Coopervision INC. | $559.05 | 2019-2024 | Myday Contact Lens |
| Amgen INC. | $265.44 | 2024-2025 | Tepezza |
| Abb Con-Cise Optical Group LLC | $242.95 | 2019-2022 | |
| Shire North American Group INC | $186.12 | 2019 | |
| Maculogix, INC. | $142.78 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $121.83 | 2025 | Xdemvy |
| Dompe US, INC. | $113.14 | 2024 | Oxervate |
| Optos, INC. | $92.63 | 2019-2021 | |
| Lkc Technologies, INC. | $90.72 | 2024 | |
| Novartis Pharmaceuticals Corporation | $67.57 | 2019-2020 | |
| Oyster Point Pharma, INC. | $46.30 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $33.30 | 2020-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $21.77 | 2021 | |
| Sun Pharmaceutical Industries INC. | $17.26 | 2019 | |
| Visioneering Technologies, INC. | $8.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Luckey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.